Position in RXST
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$398,163
-$2,611,863 QoQ
Shares Held
82,607
-83.1% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 151 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,280,904,557 across 102 Medical Devices names. RXST ranks #59 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
17,260,943 | $5,434,435,284 | |
| 2 | MDT |
Medtronic plc
|
27,784,471 | $2,173,579,157 | |
| 3 | EW |
Edwards Lifesciences Corp
|
22,783,175 | $2,060,966,003 | |
| 4 | ABT |
Abbott Laboratories
|
15,095,898 | $1,369,801,775 | |
| 5 | BSX |
Boston Scientific Corp
|
23,907,838 | $1,020,386,517 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
10,329,164 | $661,169,779 | |
| 7 | PEN |
Penumbra Inc
|
1,071,454 | $338,311,597 | |
| 8 | DXCM |
Dexcom Inc
|
3,325,095 | $223,945,140 |
All Filings in RXST
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $398,163 | 82,607 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,010,026 | 488,641 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,632,069 | 252,598 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $924,906 | 102,882 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $443,911 | 34,147 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,110,773 | 162,803 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,182,566 | 34,397 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,515,768 | 192,510 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $11,132,410 | 185,016 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $16,039,315 | 310,960 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $24,052,491 | 596,540 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $15,383,147 | 551,565 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $15,555,858 | 540,134 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,432,640 | 565,506 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $148,060 | 11,686 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $135,024 | 11,252 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $155,006 | 11,009 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $101,850 | 8,227 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $60,828 | 5,407 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $51,249 | 4,045 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||